Functional Selectivity of a Biased Cannabinoid-1 Receptor (CB
Journal
ACS pharmacology & translational science
ISSN: 2575-9108
Titre abrégé: ACS Pharmacol Transl Sci
Pays: United States
ID NLM: 101721411
Informations de publication
Date de publication:
11 Jun 2021
11 Jun 2021
Historique:
received:
06
02
2021
entrez:
21
6
2021
pubmed:
22
6
2021
medline:
22
6
2021
Statut:
epublish
Résumé
Seven-transmembrane receptors signal via G-protein- and β-arrestin-dependent pathways. We describe a peripheral CB
Identifiants
pubmed: 34151207
doi: 10.1021/acsptsci.1c00048
pmc: PMC8204328
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1175-1187Informations de copyright
Not subject to U.S. Copyright. Published 2021 by American Chemical Society.
Déclaration de conflit d'intérêts
The authors declare the following competing financial interest(s): G.K., R.C., and M.R.I. are listed as co-inventors on two US Government patents covering (S)-MRI-1891. The remaining authors declare no competing interests.
Références
J Mol Endocrinol. 2015 Feb;54(1):75-89
pubmed: 25510402
Mol Pharmacol. 2015 Apr;87(4):747-65
pubmed: 25657338
Mol Pharmacol. 2007 Feb;71(2):549-57
pubmed: 17090705
ACS Chem Biol. 2018 Apr 20;13(4):1038-1047
pubmed: 29485852
Nature. 2017 Jul 27;547(7664):468-471
pubmed: 28678776
Cell. 2016 Oct 20;167(3):750-762.e14
pubmed: 27768894
Mol Cell Endocrinol. 2013 Jun 15;372(1-2):116-27
pubmed: 23541635
Mol Pharmacol. 2017 Feb;91(2):75-86
pubmed: 27895162
Nature. 2009 Feb 26;457(7233):1146-9
pubmed: 19122674
Cannabis Cannabinoid Res. 2017 Mar 01;2(1):48-60
pubmed: 28861504
Trends Pharmacol Sci. 2014 Jul;35(7):308-16
pubmed: 24878326
Cell Metab. 2013 Apr 2;17(4):475-90
pubmed: 23562074
Mol Pharmacol. 2015 Aug;88(2):368-79
pubmed: 26044547
Mol Pharmacol. 2007 Dec;72(6):1557-66
pubmed: 17895407
J Clin Invest. 2010 Aug;120(8):2953-66
pubmed: 20664173
Psychopharmacology (Berl). 2006 Jan;184(1):26-35
pubmed: 16328376
Annu Rev Pharmacol Toxicol. 2012;52:179-97
pubmed: 21942629
Cell Metab. 2012 Aug 8;16(2):167-79
pubmed: 22841573
J Neurochem. 2016 Nov;139(3):396-407
pubmed: 27513693
Nat Commun. 2014 Aug 01;5:4589
pubmed: 25081814
Science. 2014 Jan 3;343(6166):94-8
pubmed: 24385629
Pharmacol Rev. 2006 Sep;58(3):389-462
pubmed: 16968947
Trends Pharmacol Sci. 2007 Aug;28(8):416-22
pubmed: 17644195
Trends Pharmacol Sci. 2014 Sep;35(9):434-41
pubmed: 25042457
Int J Neuropsychopharmacol. 2010 Sep;13(8):1103-13
pubmed: 20426883
Mol Pharmacol. 2007 Jun;71(6):1512-24
pubmed: 17384224
Endocrinology. 2005 Sep;146(9):3757-64
pubmed: 15919751
Pharmacol Ther. 2006 Jun;110(3):465-502
pubmed: 16460808
Nature. 2016 Dec 22;540(7634):602-606
pubmed: 27851727
Neuropharmacology. 2016 Aug;107:201-214
pubmed: 26970018
N Engl J Med. 2005 Nov 17;353(20):2121-34
pubmed: 16291982
PLoS Genet. 2019 Oct 17;15(10):e1008424
pubmed: 31622341
Psychopharmacology (Berl). 2009 Jul;205(1):171-4
pubmed: 19300982
Br J Pharmacol. 2020 Jul;177(13):2923-2931
pubmed: 32052419
Lancet. 2005 Apr 16-22;365(9468):1389-97
pubmed: 15836887
JCI Insight. 2016 Jul 21;1(11):
pubmed: 27525312
J Neurochem. 2008 Jul;106(1):70-82
pubmed: 18331587
J Mol Endocrinol. 2010 Feb;44(2):75-85
pubmed: 19620237